1 domain / 2 areas / 1 specialization
Maxim Group
Data updated
Maxim Group LLC is a New York-based full-service investment bank, securities firm, and wealth management platform that provides investment banking, capital markets, research, sales and trading, and private wealth services. Public sources list its headquarters in New York, NY, with offices in Florida, New Jersey, and Connecticut.
In the psychedelic ecosystem, Maxim Group matters primarily as a Wall Street coverage and capital-markets participant rather than as a dedicated psychedelic investor. Its research platform has covered multiple psychedelic-focused public companies, and its investment-banking business also works across healthcare and biotechnology, which places it near the financing activity around the sector.
Investor Context
Institutional InvestorsInvestment Context
This stakeholder is listed as an Institutional Investor within Institutional Investors. Its public geography context is global. Public stage signals include Growth / Late Stage, Public Markets, and Multi-Stage. Public focus areas include Drug Development.
Maxim Group is best understood as a public-markets investment bank with a broad healthcare and biotech orientation, plus equity research and capital-raising capabilities that can intersect with psychedelic companies. Its public psychedelic relevance appears to come through analyst coverage, conference participation, and financing/advisory activity around listed healthcare names rather than a specialty psychedelic mandate. That makes it relevant to Blossom as an ecosystem stakeholder that can influence visibility, access to capital, and market narratives for public psychedelic issuers.
Investor Type
Institutional Investor
Geographic Scope
Global
Psychedelic Focus
No Public Psychedelic Focus
Engagement
Active
Investment Stage Focus
Investment Focus Areas
Quick Facts
- HQ
- New York, NY, United States
- Website
- Visit